Jardiance (empagliflozin) Pros and Cons
- Jardiance (empagliflozin) is an oral diabetes medicine that must be taken only once daily.
- Clinical trials have shown that it can lower HbA1c by 1% (HbA1c is a measure of blood sugar control over the past 3 months).
- Jardiance (empagliflozin) is less likely to cause weight gain and hypoglycemia (low blood sugar) compared to other oral diabetes medications.
- In people with established cardiovascular disease and diabetes, this medicine can reduce the risk of death from heart attack and stroke.
- Jardiance (empagliflozin) can increase the risk of serious urinary tract infections and vaginal yeast infections.
- It can lead to increased urination, including at night.
- There is no low-cost generic version available. It is only available under the brand name Jardiance.
- Jardiance (empagliflozin) does not treat adults with type 1 diabetes or diabetic ketoacidosis.
- People with severe kidney problems or those receiving dialysis cannot take this medicine.
SOCIAL